We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
VVY.AS

Price
1.75
Stock movement down
-0.09 (-4.89%)
Company name
Vivoryon Therapeutics NV
Exchange
(AS
,
Currency
EUR
)
Sector
Healthcare >
Biotechnology
Market cap
45.62M
Ent value
31.60M
Price/Sales
-
Price/Book
1.74
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
3.30%
1 year return
249.30%
3 year return
-42.88%
5 year return
-15.15%
10 year return
-20.90%
Last updated: 2025-04-05

DIVIDENDS

VVY.AS does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales-
Price to Book1.74
EV to Sales-

FINANCIALS

Per share

Per share data
Current share count26.07M
EPS (TTM)-1.01
FCF per share (TTM)-1.61

Income statement

Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-159.00K
Operating income (TTM)-26.45M
Net income (TTM)-26.29M
EPS (TTM)-1.01
EPS (1y forward)-0.73

Margins

Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash18.56M
Net receivables0.00
Total current assets29.81M
Goodwill0.00
Intangible assets941.00K
Property, plant and equipment743.00K
Total assets30.83M
Accounts payable2.89M
Short/Current long term debt0.00
Total current liabilities3.18M
Total liabilities4.55M
Shareholder's equity26.28M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-41.98M
Capital expenditures (TTM)22.50K
Free cash flow (TTM)-42.00M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-100.03%
Return on Assets-85.27%
Return on Invested Capital-100.03%
Cash Return on Invested Capital-159.82%

STOCK INFORMATION

Stock chart

Stock price data
Open1.84
Daily high1.84
Daily low1.68
Daily Volume121K
All-time high26.50
1y analyst estimate4.85
Beta1.99
EPS (TTM)-1.01
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
VVY.ASS&P500
Current price drop from All-time high-93.40%-17.56%
Highest price drop-98.41%-56.47%
Date of highest drop17 Apr 20249 Mar 2009
Avg drop from high-57.91%-11.07%
Avg time to new high430 days12 days
Max time to new high2337 days1805 days
COMPANY DETAILS
VVY.AS (Vivoryon Therapeutics NV) company logo
Marketcap
45.62M
Marketcap category
Small-cap
Description
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.
Employees
15
Website
https://www.vivoryon.com
Investor relations
-
SEC filings
VVY.AS SEC filings
CEO
Country
Netherlands
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved